Dreyfuss.berkeley.2010

225 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
225
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • PROB in all these cases = S.Ct. didn’t really tell us why something is in or out, so even though opinion in Bilski said you can’t take a restrictive approach to what is considered patentable (as fed cir had done), it still agreed with Fed Cir that hedging method at issue in Bilski wasn’t patentable. It just plain forgot to tell us why. But there’s a powerful hint = number of times the term “preempt” was used by the court PROB w that: NO ONE KNOWS WHAT PREEMPT MEANS. Do gene patents preempt the field? Not a term scientists would use
  • ×